Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.254EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.122EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.431EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.6 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.626EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.629EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.61 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.524EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.15.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.59 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DJ.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.193EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.68 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.84 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used